Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Estrogen receptor mutations and changes in downstream gene expression and signaling patterns. Clinical cancer research : an official journal of the American Association for Cancer Research. .
Fuqua SA, Naso RB. A comparison of the intracellular precursor polyproteins of simian sarcoma-associated virus [SiSV(SiAV)] and three human virus isolates: HL23V, HEL12V and A1476V. J Gen Virol. 1982 Sep;62 (Pt 1):49-63. doi: 10.1099/0022-1317-62-1-49. PubMed PMID: 6290596.
Fuqua SA, Moretti-Rojas IM, Schneider SL, McGuire WL. P-glycoprotein expression in human breast cancer cells. Cancer Res. 1987 Apr 15;47(8):2103-6. PubMed PMID: 3828999.
Merkel DE, Fuqua SA, Hill SM, McGuire WL. P-glycoprotein gene amplification or overexpression is not detected in clinical breast cancer specimens. Prog Clin Biol Res. 1988;276:61-73. PubMed PMID: 2902641.
Moretti-Rojas I, Fuqua SA, Montgomery RA 3rd, McGuire WL. A cDNA for the estradiol-regulated 24K protein: control of mRNA levels in MCF-7 cells. Breast Cancer Res Treat. 1988 May;11(2):155-63. doi: 10.1007/bf01805839. PubMed PMID: 3401605.
Osborne CK, Ross CR, Coronado EB, Fuqua SA, Kitten LJ. Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model. Breast Cancer Res Treat. 1988 Jul;11(3):211-9. doi: 10.1007/BF01807279. PubMed PMID: 3167228.
Hill SM, Fuqua SA, Chamness GC, Greene GL, McGuire WL. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism. Cancer Res. 1989 Jan 1;49(1):145-8. PubMed PMID: 2562795.
Fuqua SA, Merkel DE, McGuire WL. Laboratory aspects of multidrug resistance. Cancer Treat Res. 1989;42:45-59. doi: 10.1007/978-1-4613-1747-0_3. Review. PubMed PMID: 2577107.
Merkel DE, Fuqua SA, McGuire WL. P-glycoprotein in breast cancer. Cancer Treat Res. 1989;48:97-105. doi: 10.1007/978-1-4613-1601-5_7. Review. PubMed PMID: 2577143.
McGuire SE, Fuqua SA, Naylor SL, Helin-Davis DA, McGuire WL. Chromosomal assignments of human 27-kDa heat shock protein gene family. Somat Cell Mol Genet. 1989 Mar;15(2):167-71. doi: 10.1007/bf01535078. PubMed PMID: 2538929.
Merkel DE, Fuqua SA, Tandon AK, Hill SM, Buzdar AU, McGuire WL. Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J Clin Oncol. 1989 Aug;7(8):1129-36. doi: 10.1200/JCO.1989.7.8.1129. PubMed PMID: 2569033.
Fuqua SA, Blum-Salingaros M, McGuire WL. Induction of the estrogen-regulated "24K" protein by heat shock. Cancer Res. 1989 Aug 1;49(15):4126-9. PubMed PMID: 2743305.
Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA, Ramasharma K, Marshall M, Li CH. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol. 1989 Nov;3(11):1701-9. doi: 10.1210/mend-3-11-1701. PubMed PMID: 2558302.
Fuqua SA, Falette NF, McGuire WL. Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay. J Natl Cancer Inst. 1990 May 16;82(10):858-61. doi: 10.1093/jnci/82.10.858. PubMed PMID: 2332903.
Schneider SL, Fuqua SA, Speeg KV, Tandon AK, McGuire WL. Isolation and characterization of an adriamycin-resistant breast tumor cell line. In Vitro Cell Dev Biol. 1990 Jun;26(6):621-8. doi: 10.1007/bf02624212. PubMed PMID: 1972704.
Falette NS, Fuqua SA, Chamness GC, Cheah MS, Greene GL, McGuire WL. Estrogen receptor gene methylation in human breast tumors. Cancer Res. 1990 Jul 1;50(13):3974-8. PubMed PMID: 2354445.
Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL. HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res. 1990 Jul 15;50(14):4332-7. PubMed PMID: 1973070.
Fuqua SA, Fitzgerald SD, McGuire WL. A simple polymerase chain reaction method for detection and cloning of low-abundance transcripts. Biotechniques. 1990 Aug;9(2):206-11. PubMed PMID: 1698071.
Borg A, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Olsson H, Killander D, McGurie WL. Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br J Cancer. 1991 Jan;63(1):136-42. doi: 10.1038/bjc.1991.28. PubMed PMID: 1989653; PubMed Central PMCID: PMC1971653.
Fuqua SA, Fitzgerald SD, Chamness GC, Tandon AK, McDonnell DP, Nawaz Z, O'Malley BW, McGuire WL. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 1991 Jan 1;51(1):105-9. PubMed PMID: 1988075.
Fuqua SA, Hill SM, Chamness GC, Benedix MG, Greene GL, O'Malley BW, McGuire WL. Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors. J Natl Cancer Inst. 1991 Aug 21;83(16):1157-60. doi: 10.1093/jnci/83.16.1157. PubMed PMID: 1679459.
McGuire WL, Chamness GC, Fuqua SA. Estrogen receptor variants in clinical breast cancer. Mol Endocrinol. 1991 Nov;5(11):1571-7. doi: 10.1210/mend-5-11-1571. Review. PubMed PMID: 1779964.
McGuire WL, Chamness GC, Fuqua SA. The importance of normal and abnormal oestrogen receptor in breast cancer. Cancer Surv. 1992;14:31-40. Review. PubMed PMID: 1423328.
McGuire WL, Chamness GC, Fuqua SA. Abnormal oestrogen receptor in clinical breast cancer. Eur J Cancer. 1992;28(2-3):309-10. doi: 10.1016/s0959-8049(05)80040-1. Review. PubMed PMID: 1591044.
Fuqua SA, Fitzgerald SD, Allred DC, Elledge RM, Nawaz Z, McDonnell DP, O'Malley BW, Greene GL, McGuire WL. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res. 1992 Jan 15;52(2):483-6. PubMed PMID: 1728420.
Fuqua SA. Where is the lesion in hormone-independent breast cancer?. J Natl Cancer Inst. 1992 Apr 15;84(8):554-5. doi: 10.1093/jnci/84.8.554. PubMed PMID: 1556761.
Ciocca DR, Fuqua SA, Lock-Lim S, Toft DO, Welch WJ, McGuire WL. Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res. 1992 Jul 1;52(13):3648-54. PubMed PMID: 1617638.
McGuire WL, Chamness GC, Fuqua SA. Abnormal estrogen receptor in clinical breast cancer. J Steroid Biochem Mol Biol. 1992 Sep;43(1-3):243-7. doi: 10.1016/0960-0760(92)90214-4. Review. PubMed PMID: 1525064.
Fuqua SA, Allred DC, Auchus RJ. Expression of estrogen receptor variants. J Cell Biochem Suppl. 1993;17G:194-7. doi: 10.1002/jcb.240531135. Review. PubMed PMID: 8007697.
Elledge RM, Fuqua SA, Clark GM, Pujol P, Allred DC, McGuire WL. Prognostic significance of p53 gene alterations in node-negative breast cancer. Breast Cancer Res Treat. 1993;26(3):225-35. doi: 10.1007/BF00665800. PubMed PMID: 8251647.
Fuqua SA, Allred DC, Elledge RM, Krieg SL, Benedix MG, Nawaz Z, O'Malley BW, Greene GL, McGuire WL. The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain. Breast Cancer Res Treat. 1993;26(2):191-202. doi: 10.1007/bf00689692. PubMed PMID: 8219256.
Allred DC, O'Connell P, Fuqua SA. Biomarkers in early breast neoplasia. J Cell Biochem Suppl. 1993;17G:125-31. doi: 10.1002/jcb.240531125. Review. PubMed PMID: 8007690.
Elledge RM, Fuqua SA, Clark GM, Pujol P, Allred DC. William L. McGuire Memorial Symposium. The role and prognostic significance of p53 gene alterations in breast cancer. Breast Cancer Res Treat. 1993;27(1-2):95-102. doi: 10.1007/BF00683196. PubMed PMID: 8260732.
Encarnación CA, Ciocca DR, McGuire WL, Clark GM, Fuqua SA, Osborne CK. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen. Breast Cancer Res Treat. 1993;26(3):237-46. doi: 10.1007/BF00665801. PubMed PMID: 8251648.
Fuqua SA, Chamness GC, McGuire WL. Estrogen receptor mutations in breast cancer. J Cell Biochem. 1993 Feb;51(2):135-9. doi: 10.1002/jcb.240510204. Review. PubMed PMID: 8440747.
Allred DC, Clark GM, Elledge R, Fuqua SA, Brown RW, Chamness GC, Osborne CK, McGuire WL. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst. 1993 Feb 3;85(3):200-6. doi: 10.1093/jnci/85.3.200. PubMed PMID: 8423624.
Ciocca DR, Clark GM, Tandon AK, Fuqua SA, Welch WJ, McGuire WL. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst. 1993 Apr 7;85(7):570-4. doi: 10.1093/jnci/85.7.570. PubMed PMID: 8455204.
Wiebe VJ, Osborne CK, Fuqua SA, DeGregorio MW. Tamoxifen resistance in breast cancer. Crit Rev Oncol Hematol. 1993 Jun;14(3):173-88. doi: 10.1016/1040-8428(93)90008-r. Review. PubMed PMID: 8397846.
Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Osborne CK, Fuqua SA. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res. 1993 Oct 1;53(19):4443-8. PubMed PMID: 8402609.
Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst. 1993 Oct 6;85(19):1558-70. doi: 10.1093/jnci/85.19.1558. Review. PubMed PMID: 8411230.
Zhang QX, Borg A, Fuqua SA. An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer. Cancer Res. 1993 Dec 15;53(24):5882-4. PubMed PMID: 8261397.
Castles CG, Fuqua SA, Klotz DM, Hill SM. Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line. Cancer Res. 1993 Dec 15;53(24):5934-9. PubMed PMID: 8261406.
Encarnacion CA, Fuqua SA. Estrogen receptor variants in breast cancer. Cancer Treat Res. 1994;71:97-109. doi: 10.1007/978-1-4615-2592-9_6. Review. PubMed PMID: 7946961.
Allred DC, O'Connell P, Fuqua SA, Osborne CK. Immunohistochemical studies of early breast cancer evolution. Breast Cancer Res Treat. 1994;32(1):13-8. doi: 10.1007/bf00666202. Review. PubMed PMID: 7819582.
Fuqua SA, Benedix MG, Krieg S, Weng CN, Chamness GC, Oesterreich S. Constitutive overexpression of the 27,000 dalton heat shock protein in late passage human breast cancer cells. Breast Cancer Res Treat. 1994;32(2):177-86. doi: 10.1007/bf00665768. PubMed PMID: 7865847.
Fuqua SA, Oesterreich S, Hilsenbeck SG, Von Hoff DD, Eckardt J, Osborne CK. Heat shock proteins and drug resistance. Breast Cancer Res Treat. 1994;32(1):67-71. doi: 10.1007/BF00666207. Review. PubMed PMID: 7819588.
Osborne CK, Fuqua SA. Mechanisms of tamoxifen resistance. Breast Cancer Res Treat. 1994;32(1):49-55. doi: 10.1007/BF00666205. Review. PubMed PMID: 7819585.
Allred DC, Elledge R, Clark GM, Fuqua SA. The p53 tumor-suppressor gene in human breast cancer. Cancer Treat Res. 1994;71:63-77. doi: 10.1007/978-1-4615-2592-9_4. Review. PubMed PMID: 7946959.
Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SA, Hilsenbeck SH, Chamness GC, Osborne CK. Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer. J Clin Oncol. 1994 Mar;12(3):467-74. doi: 10.1200/JCO.1994.12.3.467. PubMed PMID: 8120545.
Stein D, Wu J, Fuqua SA, Roonprapunt C, Yajnik V, D'Eustachio P, Moskow JJ, Buchberg AM, Osborne CK, Margolis B. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J. 1994 Mar 15;13(6):1331-40. doi: 10.1002/j.1460-2075.1994.tb06386.x. PubMed PMID: 7907978; PubMed Central PMCID: PMC394949.
What would you like to do?